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Introduction: The most common congenital abnormality of the penis is 
hypospadias. Although the main treatment is surgical; hormone therapy with 
dihydrotestosterone is also used. 
Materials and Methods: This randomized clinical trial was carried out 
between January 2012 and December 2017 on 79 children with hypospadias 
(in the Clinic of Pediatric Surgery, Clinical Centre University of Sarajevo). Their 
mean age was 38.2±2.8 months. GroupI included 36 children whom were 
treated with 2.5% dihydrotestosterone gel which was applied twice a day to 
the penile shaft and glans for one month prior to surgery. GroupII included 43 
children whom did not receive any treatment preoperatively. 
Results: Mean age of patients in group I was 37.3±6.3 months and in group 
II it was 39.1±5.9 months which were comparable. Complications occurring 
postoperatively were: urethrocutaneous fistula in 6 patients (13.9%) in group 
II, versus 1 patient (2.7%) in group I. There were 2 patients with meatalstenosis 
in group II (4.7%), and 3 (8.3%) in group I. Finally, there was a significant 
difference (p<0.05) between the overall reoperation rates between groups 
(p<0.05). 
Conclusion: Pretreatment with 2.5% dihydrotestosterone transdermal gel 







received: 14 January 2019
accepted: 26 January 2019
Published online: 15 June 2019    
28
Iranian Journal of Pediatric Surgery        Vol.5    No.1/2019
This open-access article is distributed under the terms of the Creative 
Commons Attribution Non Commercial 4.0 License (CC BY-NC 4.0).
Downloaded from:  http://journals.sbmu.ac.ir/irjps
 Introduction
Hypospadias the most common congenital 
abnormality of the penis has an incidence of 1 in 250 
male newborns.1 Hypospadias surgery is carried 
out in order to position the opening of urethra at the 
correct anatomic position on the tip of the glans. 
Surgical procedures are challenging and have well 
known complications such as: glans dehiscence, 
urethrocutaneous fistula, meatal stenosis and 
unacceptable cosmetic results. Some believe that 
hormonal stimulation prior to surgery may result 
in better functional and cosmetic outcomes.1 This 
approach which was first described in 1971 is a 
matter of debate. Hormonal stimulation (using: 
testosterone, Dihydrotestosterone (DHT) or human 
chorionic gonadotropin)2 before surgery is used in 
cases with proximal hypospadias or small penile or 
glanular size.3 It can inhance vascularization of the 
prepuce and also increases penile size and glanular 
diameter.4,5,6 It is useful to the surgical technique 
since scarcity of glanular and penile tissue may 
compremise ventral closure of the neourethra. 
Testosterone is usefull wether it is applied locally 
or systemic.7 It seems that externally administered 
DHT is more effective than testosterone (because 
it does not require 5 alpha-reductase).8 
Materials and Methods
During 6 years (January 2012 to December 2017) 
79 cases of primary hypospadias with a mean 
age of 38.2±2.8 months that underwent the TIP 
(tubularized incised plate urethroplasty) procedure 
at the Clinic for Pediatric Surgery of the Clinical 
Center University of Sarajevo were studied. 
Informed consents were obtained from parents 
and the children were randomized into 2 groups. 
Group1 which consisted of 36 cases received 
topical DHT 2.5% transdermal gel twice a day 
directly onto the penile shaft and glans for a month 
preoperatively (it was discontinued 2 weeks before 
the operation) and group 2 which consisted of 43 
cases did not receive any kind of hormonal therapy. 
Exclusion criteria were: any endocrinological or 
clinical evidence of hypopituitarism and having a 
history of hypospadias surgery.
All cases underwent the TIP urethroplasty 
procedure with or without chordee correction.
Results
Mean age of patients in the 2 groups were similar 
(group1: 37.3±6.3 months and group2: 39.1±5.9). 
Patient characteristics for the 2groups are shown 
in Table 1.
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Table 1: Patients characteristics
Group 1 Group 2
Coronal 11 (30.5%) 20 (46.5%)
Penile 25 (69.5%) 23 (53.5%)
Chordae corrections 28 (77.7%) 30 (69.7%)
Orchidopexy 1(2.7%) 1(2.7%)
Herniectomy 1(2.7%) 2(5.4%)
Total 36 (100%) 43 (100%)
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At 1-year follow-up urethrocutaneous fistula was 
found in 1 patient (2.7%) in group 1 and 6 patients 
(13.9%) in group 2 had. Figure 1 Also glanular 
dehiscence was only found in 2 patients (4.7%) 
in group. 2 In group 1 three patients (8.3%) had 
meatal stenosis, compared to 2 patients (4.7%) in 
group. 2 In group 1 and 2 one patient had a urethral 
stricture and scar formation. Analysis of the overall 
complications revealed that fistula, glanular 
dehiscence and meatal stenosis were found in 
8.9%, 2.5% and 6.3% of the patients, respectively.
A significant difference was found between the 
reoperation rates in the 2 groups (p<0.05). Eight 
patients in group2 needed reoperation due to 
fistula and/or dehiscence, compared to only 1 
patient in group. 1 We had no serious hormone 
therapy related complications in our patients. Only 
2 parents (5.5%) reported penile skin symptoms 
such as itching and redness at the first couple of 
weeks of treatment which disappeared after 2 
weeks of ongoing therapy. Parents also reported 
penile skin hyperpigmentation during treatment 
which was back to normal after topical treatment 
finished. 
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Figure 1: Comparison of complications between groups 1 and 2
Discussion
Surgical treatment of hypospadias is done in ordre 
to inhance the aesthetic and functional aspects of 
the penis. Hormone therapy before surgery aims 
to achieve superior surgical results. Testosterone 
has the ability to increase penile size in pre-
pubertal boys. This fact helps the surgical repair 
of hypospadias, since having more tissue to work 
with and a more robust vascular structure improves 
healing and makes correction easier and lowers the 
risk of failure.4 In a prospective RCT by Bastos, 
et al. they showed an absolute increase in the 
number of blood vessels and vascular volume 
density after using a 1% testosterone ointment.6 
Another study by Monfort, et al. in 1982 using 5% 
dihydrotestosterone (DHT) cream also proved its 
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capability in stimulating growth of penile length and 
circumference.2 A study by Kaya, et al. showed that 
using DHT topical cream preoperatively reduced 
complication rates of TIP surgery in hypospedias 
patients.4 There are not many prospective clinical 
trials that have assessed complication rates related 
to preoperative hormonal therapy in hypospadias 
patients. Recently an RCT by Asgari, et al. showed 
that preoperative testosterone administration 
is beneficial in reducing complications.9 Post 
operative complications of hypospadiasis repair 
such as urethrocutaneous fistula, stricture and scar 
formation are not rare, even in cases when an expert 
surgeon carries out careful preoperative evaluation 
and performs precise surgical techniques and post 
operative care.10 Thus, any method by which the 
natural tissue of this anatomic region is increased 
can be useful in reducing the complications of 
repair especially in severe cases of hypospadias; 
for example in cases of micropenis, IV testosterone 
can facilitate glanuloplasty by enlarging the glans.11 
In our study we found that patients with glanular 
dehiscence which needed reoperation were 
significantly higher in group 2 compared to 
group 1. The number of fistula formation was 
higher in the first year of follow-up in children 
not receiving DHT; although this difference was 
not statistically meaningfull. In all, our results are 
consistent with other studies in the literature. There 
is no consensus regarding the exact indication of 
preoperative hormonal therapy but in a study by 
Snodgrass et al. they reported that 63% of patients 
received testostrone stimulation preoperatively 
without undergoing any endocrine testing, when 
patients had glans width <14 mm, which is less 
than the average normal newborn glans diameter.12 
Indications have been considered for administering 
hormones such as ventral curvature, a small-
appearing penis and/or glans and also before 
reoperation inorder to increase the availability and 
vascularity of penile skin. Side effects of treatment 
with androgens include: aggressive behavior, pubic 
hair growth and adult full height compromise which 
will all regress afer treatment has stopped. 13,14 but 
we did not receive any compliments regarding 
these side effects in our study. Histological studies 
have shown that androgens increased the number 
and density of blood vessels, supporting a theory of 
formation of new blood vessels.15 Although many 
years of research have been dedicated to surgical 
treatment of proximal hypospadias it is still one 
of the most challenging conditions in pediatric 
urology and result in many unwanted postoperative 
complications. We recorded complication rates 
such as fistulas, urethral strictures, diverticula, 
meatal stenosis, glanular dehiscence and scar 
formation up to one year after surgery and found 
that pre-treatment with DHT can be considered 
to be effective in reducing complications and 
improving the cosmetic outcomes of hypospadias 
repair. In a randomized, controlled study of DHT 
gel administration before hypospadias surgery, 
complication rates were lower in the DHT treatment 
group (2.7%) compared to the control group 
(18.6%), thus the need for reoperation was lower 
in the DHT treatment group and better cosmetic 
outcomes were obtained due to lower rates of 
scar formation. Considering the results of studies 
evaluating the use of preoperative testosterone 
therapy in male patients with hypospadias 
we can assume that preoperative testosterone 
therapy is effective in increasing penile length 
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and circumference which helps in reducing post 
operative complications and is consistent with the 
findings of our study.
Conclusion
Penile augmentation with DHT transdermal gel 
is beneficial in terms of increasing the size of 
the phallus and penile skin in hypospadias. We 
conclude that DHT transdermal gel can be safely 
used to improve the results of reconstructive 
surgery on hypospadias. 
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